✨ Your Portfolio is fetched and updated from zerodha.
Nano Agriculture

Indo US Bio-Tech Ltd.

INDOUS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹267 Cr.
P/E
15.02

Indo US Bio-Tech Ltd.

  • Indo US Bio-Tech
  • Tierra Agrotech
  • Kotyark Industries

FAQs on Indo US Bio-Tech Ltd. Shareprice

Indo US Bio-Tech has given better returns compared to its competitors.
Indo US Bio-Tech has grown at ~42.06% over the last 3yrs while peers have grown at a median rate of -6.0%

Indo US Bio-Tech is not expensive.
Latest PE of Indo US Bio-Tech is 15.1, while 3 year average PE is 37.08.
Also latest EV/EBITDA of Indo US Bio-Tech is 13.69 while 3yr average is 27.23.

View FAQ's On Business

Growth Table

  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Balance Sheet

  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Cash Flow

  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Quarterly Results

  • Indo US Bio-Tech Ltd.
  • Tierra Agrotech
  • Kotyark Industries

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Indo US Bio-Tech Ltd. Financials

Balance sheet of Indo US Bio-Tech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Indo US Bio-Tech is increasing.
Latest net debt of Indo US Bio-Tech is ₹14.35 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹12.13 Crs.

Yes, profit is increasing.
The profit of Indo US Bio-Tech is ₹17.8 Crs for TTM, ₹16.27 Crs for Mar 2025 and ₹8.25 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Indo US Bio-Tech latest dividend payout ratio is 3.08% and 3yr average dividend payout ratio is 3.08%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech